Lauren Sciences LLC Founder & CEO Susan Rosenbaum sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.
The privately-held New York-based biotechnology company is developing its V-Smart Nanomedicines to treat brain diseases. It was announced last year the company was awarded an AU$1M translational grant from FightMND, which is based in Australia.